Tidewave Bio is developing a universal, off-the-shelf cancer immunotherapy platform for solid tumors, combining gene-modified allogeneic antigen-presenting cells with a patient's own tumor biopsy.
Septembre 2026
USA - California
Vaccins
Biotech - Lead optimization